Marex Group plc

Position in NVAX — Novavax Inc

CIK 1997464 London, X0

Position in NVAX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$334,353

+$45,432 QoQ

Shares Held

35,494

0.0% QoQ

Ownership

0.022%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#111

of 263 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Marex Group plc holds $88,179,553 across 55 Biotechnology names. NVAX ranks #28 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TGTX	Tg Therapeutics, Inc.	276,178	$15,173,219
2	SANA	Sana Biotechnology, Inc.	3,989,100	$13,921,959
3	NTLA	Intellia Therapeutics, Inc.	623,600	$10,551,312
4	CRSP	CRISPR Therapeutics AG	170,584	$9,303,650
5	DNLI	Denali Therapeutics Inc.	295,631	$7,603,629
6	MRNA	Moderna, Inc.	88,575	$6,202,907
7	QURE	uniQure N.V.	81,500	$3,753,890
8	ABVX	Abivax S.A.	27,336	$3,642,795

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$334,353	35,494	0.0%	Shares	Defined	2026-08-14
2026-03-31	$288,921	35,494	0.0%	Shares	Defined	2026-05-13
2025-12-31	$238,519	35,494	+23.8%	Shares	Defined	2026-02-12
2025-09-30	$248,525	28,665	-39.0%	Shares	Defined	2025-11-14
2025-06-30	$295,986	46,982	-2.7%	Shares	Defined	2025-08-19
2025-03-31	$309,583	48,297	+93.8%	Shares	Defined	2026-04-02
2024-12-31	$200,332	24,917	-15.5%	Shares	Defined	2026-04-02
2024-09-30	$372,332	29,480	-12.6%	Shares	Defined	2026-04-07
2024-06-30	$427,009	33,729	+23.6%	Shares	Defined	2026-04-02
2024-03-31	$130,484	27,298	+29.4%	Shares	Defined	2026-04-02
2023-12-31	$101,288	21,102	+54.9%	Shares	Defined	2026-04-02
2023-09-30	$98,623	13,622	-9.8%	Shares	Defined	2026-04-02
2023-06-30	$112,230	15,105	0.0%	Shares	Defined	2026-04-02
2023-03-31	$104,677	15,105	+12.7%	Shares	Defined	2026-04-02
2022-12-31	$137,741	13,399	—	Shares	Defined	2026-04-02
No filing history on record for this holder in this stock.